Microbial metabolites isolated in screening programs for their ability to activate transcription of the tipA promoter (ptipA) in Streptomyces lividans define a class of cyclic thiopeptide antibiotics having dehydroalanine side chains ("tails"). Here we show that such compounds of heterogeneous primary structure (representatives tested: thiostrepton, nosiheptide, berninamycin, promothiocin) are all recognized by TipAS and TipAL, two in-frame translation products of the tipA gene. The Nterminal helix-turn-helix DNA binding motif of TipAL is homologous to the MerR family of transcriptional activators, while the C terminus forms a novel ligand-binding domain. ptipA inducers formed irreversible complexes in vitro and in vivo (presumably covalent) with TipAS by reacting with the second of the two C-terminal cysteine residues. Promothiocin and thiostrepton derivatives in which the dehydroalanine side chains were removed lost the ability to modify TipAS. They were able to induce expression of ptipA as well as the tipA gene, although with reduced activity. Thus, TipA required the thiopeptide ring structure for recognition, while the tail served either as a dispensable part of the recognition domain and/or locked thiopeptides onto TipA proteins, thus leading to an irreversible transcriptional activation. Construction and analysis of a disruption mutant showed that tipA was autogenously regulated and conferred thiopeptide resistance. Thiostrepton induced the synthesis of other proteins, some of which did not require tipA.Directed searches for microbial secondary metabolites that inhibit bacterial growth led to the discovery of antibiotics and thus gave rise to the traditional interpretation that their only biological relevance is to inhibit growth of competing organisms. Nevertheless, antibiotics often have alternative molecular targets and, like other secondary metabolites, elicit numerous "unexpected" effects on microbial differentiation (1-4) and mammalian cell function (1). Here we describe how a single transcriptional activator can interact with diverse thiopeptide antibiotics to elicit autogenous expression of its own promoter as well as a modulon in Streptomyces lividans (SL).
1Thiopeptides are a family of antibiotics composed of a ring structure containing highly modified amino acids and a linear peptide containing dehydroalanines extending from the ring at a pyridyl group ("tail") ( Fig. 1). They were first discovered as antibiotics synthesized by diverse bacteria including Streptomyces, Bacillus, and Micrococcus. These compounds later proved to be effective growth promotants for domestic animals (2-4), an effect whose biological basis is not clear. Thiostrepton, whose antibiotic activity is best understood, acts by binding tightly to the procaryotic ribosome and thus inhibiting translation (5-8). In a thiostrepton-producing organism, Streptomyces azureus, methylation of a specific nucleotide in the 23 S rRNA can provide resistance. Such methylated ribosomes do not bind and are therefore not sensitive to thiostrep...